Includes index.

Intro -- Colloids for Nanobiotechnology: Synthesis, Characterization and Potential Applications -- Copyright -- Contents -- Contributors -- Chapter 1: Colloids for nanobiotechnology: An introduction -- Chapter 2: Surface-enhanced Raman scattering (SERS) sensing of nucleic acids -- 2.1. Introduction -- 2.2. Indirect SERS detection of nucleic acids -- 2.3. Direct SERS detection of nucleic acids -- 2.4. Conclusions -- Acknowledgments -- References -- Chapter 3: Energy transfer with nanoparticles for in vitro diagnostics -- 3.1. Introduction -- 3.2. Semiconductor QDs

3.2.1. QDs as FRET donors for IVD -- 3.2.1.1. Enzyme sensing -- 3.2.1.2. Nucleic acid sensing -- 3.2.1.3. Immunoassays -- 3.2.2. QDs as FRET acceptors for IVD -- 3.2.2.1. Luminescence lanthanide complex as FRET donor -- 3.2.2.1.1. Nucleic acid sensing -- 3.2.2.1.2. Antibody/antigen sensing -- 3.2.2.2. UCNPs as FRET donors -- 3.2.3. QDs as FRET donors and acceptors -- 3.2.3.1. Small molecule sensing -- 3.2.3.2. Antibody/antigen sensing -- 3.3. Upconversion nanoparticles -- 3.3.1. FRET for biosensing with UCNPs -- 3.3.2. UCNPs as energy donors for IVD -- 3.3.2.1. Small molecule sensing

3.3.2.2. Nucleic acid sensing -- 3.3.2.3. Antibody/antigen sensing -- 3.4. Gold nanoparticles -- 3.4.1. AuNPs as energy acceptors for IVD -- 3.4.1.1. Nucleic acid sensing -- 3.4.1.2. Protein sensing -- 3.4.1.3. Small molecule sensing -- 3.5. Carbon quantum dots -- 3.5.1. Optical properties of CQDs -- 3.5.2. CQDs as ET donors for IVD -- 3.5.2.1. Organic dyes as ET acceptors -- 3.5.2.2. Metal nanoclusters as ET acceptors -- 3.5.2.3. QDs as ET acceptors -- 3.5.2.4. Other nanomaterials as ET acceptors/quenchers -- 3.6. Perspectives -- References -- Chapter 4: Nanoparticles for imaging application

4.1. Introduction -- 4.2. Imaging modalities -- 4.3. Nanoparticles for imaging applications -- 4.3.1. Optical imaging -- 4.3.2. Ultrasound imaging -- 4.3.3. Photoacoustic imaging -- 4.3.4. Computed tomography -- 4.3.5. Magnetic resonance imaging -- 4.3.6. Magnetic particle imaging -- 4.3.7. Positron emission tomography and single photon emission computed tomography -- 4.3.8. Multimodal imaging -- 4.4. Perspective -- References -- Chapter 5: Colloidal nanoparticles as pharmaceutical agents -- 5.1. Introduction -- 5.1.1. Nano-pharmacokinetics (Nano-PK) -- 5.1.2. Nano-pharmacodynamics (Nano-PD)

5.1.3. Multifunctional efficiency -- 5.2. Autonomous TNPs -- 5.2.1. Drug-containing TNPs -- 5.2.2. Nanoparticles with intrinsic mechanisms for the induction of cell death -- 5.2.2.1. Reactive oxygen species-generating TNPs -- 5.2.2.2. Ferroptosis induction -- 5.2.2.3. Ion overdose -- 5.2.2.4. Autophagy induction -- 5.2.2.5. Therapy besides cancer -- 5.2.2.6. Detoxifying TNPs -- 5.3. Exogenous energy-converting TNPs -- 5.3.1. Thermal therapy -- 5.3.2. Photodynamic therapy -- 5.3.3. Sonodynamic therapy -- 5.3.4. Radiotherapy -- 5.4. Immunotherapeutic nanoparticles